Analgesic Activity of Chitosan in Arthritis Rats Induced by Complete Freund's Adjuvant (CFA)
DOI:
https://doi.org/10.30595/pharmacy.v19i1.13842Keywords:
Analgetic, Chitosan, Diclofenac sodium, Hot plate, Sprague Dawley ratsAbstract
Arthritis is inflammation and pain in joints, often accompanied by stiffness and difficulty to move. The current pain treatment in arthritis is synthetic drugs that have many side effects. Chitosan’s structure similar to that of glucosamine which can be used as anti-arthritis. This study aims to evaluate the analgesic activity of chitosan in arthritic rats. The heat stimulation method with a hot plate at temperature of 55±1oC was utilized. A total of 25 male Sprague Dawley rats, weighing 150-250 g, were fed and given water ad libitum. There were grouped into group I (normal control), group II (positive control), group III (negative control, given diclofenac sodium), group IV and V (chitosan treatment at 50 and 100 mg/200g BW of rats, respectively). Arthritis in groups II to V rats were induced by subplantar injection of Complete Freund's Adjuvant (CFA) on the first day according to the Anderson method. Analgesic activity was measured every 3 days on day 17 onwards. The obtained data were analyzed using a general linear repeated measure test (p <0.05). The percentage of pain response reduction in normal control, positive control, negative control, chitosan group at 50 and 100 mg/200 g body weight (BW) were 0.30±1.73, -13.46±0.74, 20.37±1.54, 31.52±1.44, and 35.29±0.72%, respectively. Thus, chitosan can be used as an analgesic in arthritic rats.
References
Anderson AJ. 1970. Lysosomal enzyme activity in rats with adjuvant-induced arthritis. Annals of the Rheumatic Diseases. 29: 307–313.
Bachhav RS, Gulecha VS, Upasani CD. 2009. Analgesic and anti-inflammatory activity of Argyreia speciosa root. Indian Journal of Pharmacology. 41(4): 158–161. https://doi.org/10.4103/0253-7613.56066.
Barbour KE, Helmick CG, Boring M, Brady TJ. 2017. Vital signs: Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation - United States, 2013-2015. Morbidity and Mortality Weekly Report. 66(9): 246–253. https://doi.org/10.15585/mmwr.mm6609e1.
Bruyere O, Reginster JY. 2007. Glucosamine and chondroitin sulfate as therapeutic agents for knee and hip osteoarthritis. Drugs & Aging. 24(7): 573–580. https://doi.org/10.2165/00002512-200724070-00005.
Chou TC, Fu E, Shen EC. 2003. Chitosan inhibits prostaglandin E2 formation and cyclooxygenase-2 induction in lipopolysaccharide-treated RAW 264.7 macrophages. Biochemical and Biophysical Research Communications. 308(2), 403–407. https://doi.org/10.1016/s0006-291x(03)01407-4.
Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L. 2014. The global burden of rheumatoid arthritis: Estimates from the global burden of disease 2010 study. Annals of the Rheumatic Diseases. 73(7): 1316–1322. https://doi.org/10.1136/annrheumdis-2013-204627.
Dahlhamer J, Lucas J, Zelaya C. 2018. Prevalence of chronic pain and high-impact chronic pain among adults — United States, 2016. Morbidity and Mortality Weekly Report, 67(36): 1001-1006. https://doi.org/ 10.15585/mmwr.mm6736a2
DiPiro JT. 2008. Pharmacotherapy: A pathophysiologic approach (18th ed.). McGraw-Hill Medical.
Hanifah N, Darmawan E. 2015. The anti-inflammatory effects of chitosan of shrimp shell of trisik coastal in rheumatoid arthritic rat model. Pharmaciana. 5(2): 177–183. https://doi.org/10.12928/pharmaciana.v5i2.2654.
Jerosch J. 2011. Effects of glucosamine and chondroitin sulfate on cartilage metabolism in oa: outlook on other nutrient partners especially omega-3 fatty acids. International Journal of Rheumatology. 2011: 969012. https://doi.org/10.1155/2011/969012.
Kim MM, Kim SK. (2006). Chitooligosaccharides inhibit activation and expression of matrix metalloproteinase-2 in human dermal fibroblasts. FEBS Letters. 580(11): 2661–2666. https://doi.org/10.1016/j.febslet.2006.04.015.
O’Donnell S, Lagacé C, McRae L, Bancej C. 2011. Life with arthritis in Canada: A personal and public health challenge. Chronic Diseases and Injuries in Canada. 31(3): 135–136.
O’Donnell, Siobhan, Rusu, C., Hawker, G. A., Bernatsky, S., McRae, L., Canizares, M., MacKay, C., & Badley, E. M. (2015). Arthritis has an impact on the daily lives of Canadians young and old: Results from a population-based survey. BMC Musculoskeletal Disorders, 16(1), 1–8. https://doi.org/10.1186/s12891-015-0691-2
Sah Putra, S., & Darmawan, E. (2015). The Effect Of Chitosan From Local Shrimp Shell On Red Blood Cell, Hemoglobin, And Trombocyt In Rheumatoid Arthritis Induced By Cfa Model. Pharmaciana, 5(2), 185–190. https://doi.org/10.12928/pharmaciana.v5i2.2655
Taylor S, Lobo AJ. 2016. Diagnosis and treatment of inflammatory bowel disease. Hip & Pelvis. 260(1795): 19–23. https://doi.org/10.5371/hp.2017.29.4.211.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
